Journal of AIDS & Clinical Research

Support groups play a crucial role in the management and well-being of young people living with HIV (YPLWH). This study examines the impact of support groups on treatment adherence and sexual risk behaviors among this population. Using a mixed-methods approach, we surveyed 200 YPLWH participating in both online and in-person support groups and conducted in-depth interviews with 30 participants. The results indicate that participation in support groups is associated with significantly higher treatment adherence rates and lower sexual risk behaviors. The supportive environment provided by these groups enhances knowledge about HIV management, reduces stigma, and fosters a sense of community and accountability. These findings suggest that support groups are an effective intervention for improving both treatment adherence and sexual health practices among YPLWH. The study underscores the importance of integrating support group participation into comprehensive HIV care programs to address the complex needs of young individuals living with HIV.

Individuals living with HIV are at increased risk of vaccine-preventable diseases due to their compromised immune systems. The impact of these diseases on this population is multifaceted, affecting not only their health outcomes but also their quality of life and overall healthcare burden. This review explores the implications of vaccine-preventable diseases in people with HIV, examining how their immunocompromised status makes them more susceptible to infections that vaccines typically prevent. The review also addresses the effectiveness of vaccines in this group, the challenges in vaccination practices, and the strategies for improving vaccine uptake and efficacy among HIV-positive individuals. By synthesizing current research and guidelines, this paper aims to highlight the critical need for tailored vaccination strategies and enhanced healthcare measures to mitigate the risk of vaccine-preventable diseases in this vulnerable population.

HIV/AIDS remains a significant global health challenge, and there is a continuous search for novel antiviral agents. This study explores the anti-HIV activity and immunomodulatory effects of fractionated crude extracts of A. alternata, a filamentous fungus. The crude extracts were fractionated into various components, which were then tested for their potential to inhibit HIV replication and modulate immune responses. The results demonstrated that certain fractions of A. alternata exhibited substantial anti-HIV activity by reducing viral replication and enhancing the host immune response. These findings suggest that A. alternata could be a valuable source of new therapeutic agents for HIV treatment and warrant further investigation into its active compounds and mechanisms of action.

Recent advancements in HIV treatment have significantly enhanced the quality of life for individuals living with the virus. These developments, including the introduction of more effective antiretroviral therapies (ART), have been pivotal in improving patient outcomes. However, the dissemination of these treatments remains a critical challenge, particularly in low-income countries where healthcare infrastructure is limited. This paper reviews the latest progress in HIV treatment, examines the strategies employed to distribute these treatments in resource-poor settings, and discusses the barriers and potential solutions to achieving widespread access. Findings highlight that while there have been notable successes in increasing ART access, disparities persist, and addressing these inequities is essential for achieving global health goals.